NCT06904872View on ClinicalTrials.gov

Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)

PHASE2RecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 29, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Short Bowel SyndromeMalabsorption SyndromesShort Gut SyndromePost-Op ComplicationFunctional Gastrointestinal Disorders
Interventions
DRUG

Crofelemer Powder for Oral Solution

Crofelemer Powder for Oral Solution

DRUG

Matched Placebo Powder for Oral Solution

Matched Placebo Powder for Oral Solution

Trial Locations (8)

10117

NOT_YET_RECRUITING

Charité Universitätsmedizin, Berlin

18057

NOT_YET_RECRUITING

Universitätsmedizin, Rostock

20099

NOT_YET_RECRUITING

Asklepios Klinik St. Georg, Hamburg

35128

NOT_YET_RECRUITING

Ospedale Università di Padova, Padua

40138

RECRUITING

Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola-Malpighi, Bologna

45147

NOT_YET_RECRUITING

Universitätsklinikum, Essen

52074

NOT_YET_RECRUITING

Universitäatsklinik RWTH, Aachen

80131

RECRUITING

Azienda Ospedaliera Universitaria Federico II, Napoli

Sponsors
All Listed Sponsors
lead

Napo Therapeutics, S.p.A.

INDUSTRY